Internal Medicine, Hematology & Oncology · Rochester, MN
NPI
1538172143
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
975 services
Medicare patients, 2024
276
Average age 75
Drug cost, 2024
$2.2M
1,051 prescriptions
Company payments, 2025
$2,708
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepti Behl was code 99215 (office e&m - established), 558 times for 144 patients. In total Deepti Behl billed 975 services in 18 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 558 | 144 | $145.61 | $81K |
| 99214 Office E&M - Established | Office | 212 | 139 | $102.46 | $22K |
| 99205 Office E&M - New | Office | 67 | 67 | $179.44 | $12K |
| 99213 Office E&M - Established | Office | 42 | 39 | $72.55 | $3,047 |
By year: 2022 $141K for 1,126 services; 2023 $132K for 1,025 services; 2024 $121K for 975 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepti Behl prescribed most often to Medicare patients was Prochlorperazine Maleate, with 183 prescriptions and refills. In total Deepti Behl wrote 1,051 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 183 | 183 | 113 | $2,041 |
| Ondansetron Hcl Generic | 105 | 109 | 67 | $1,131 |
| Tagrisso Osimertinib Mesylate | 62 | 62 | Under 11 | $1.1M |
| Dexamethasone Generic | 59 | 62 | 36 | $1,063 |
| Prednisone Generic | 57 | 71 | 28 | $564 |
| Levothyroxine Sodium Generic | 44 | 82 | 13 | $1,581 |
| Eliquis Apixaban | 44 | 66 | Under 11 | $38K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 36 | 36 | 17 | $901 |
| Ondansetron Odt Ondansetron | 32 | 36 | 19 | $397 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 27 | 27 | 16 | $337 |
| Alprazolam Generic | 23 | 25 | Under 11 | $96.66 |
| Alecensa Alectinib Hcl | 23 | 23 | Under 11 | $429K |
| Gabapentin Generic | 20 | 20 | Under 11 | $715 |
| Lorazepam Generic | 19 | 19 | Under 11 | $48.88 |
| Imatinib Mesylate Generic | 17 | 17 | Under 11 | $4,749 |
Brand drugs: 208 claims; generic drugs: 843 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepti Behl $2,708 ($2,708 in general payments such as food, travel and fees) from 6 companies. The largest payer was Boehringer Ingelheim International GmbH with $2,320.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.